Research on the therapeutic capability of NRN1 for age-related hearing loss encourages continued investigation in otolaryngology to characterize the mechanisms of neuroprotective and regenerative effects by targeting the fundamental mechanisms of cochlear aging, such as oxidative stress, apoptosis, and structural degeneration. Here, NRN1 is linked to presbycusis.